Development Of Minimal Residual Disease (MRD) Analysis In Childhood Acute Lymphoblastic Leukaemia (ALL) By Next Generation Sequencing (NGS)

被引:0
作者
Williamson, Helen
Mountjoy, Edward
Shihab, Hashem
Bartram, Jack
Hubank, Mike
Goulden, Nicholas
Day, Ian
Roberts, Eileen
Moppett, John
Hancock, Jeremy
机构
关键词
D O I
10.1182/blood.V122.21.2569.2569
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2569
引用
收藏
页数:2
相关论文
共 50 条
[41]   Evaluation of Minimal Residual Disease (MRD) By Next Generation Sequencing (NGS) Is Highly Predictive of Progression Free Survival in the IFM/DFCI 2009 Trial [J].
Avet-Loiseau, Herve ;
Corre, Jill ;
Lauwers-Cances, Valerie ;
Chretien, Marie-Lorraine ;
Robillard, Nelly ;
Leleu, Xavier ;
Hulin, Cyrille ;
Gentil, Catherine ;
Arnulf, Bertrand ;
Belhadj, Karim ;
Brechignac, Sabine ;
Garderet, Laurent ;
Karlin, Lionel ;
Marit, Gerald ;
Benboubker, Lotfi ;
Orsini-Piocelle, Frederique ;
Royer, Bruno ;
Drenou, Bernard ;
Tiab, Mourad ;
Lamy, Thierry ;
Macro, Margaret ;
Richardson, Paul G. ;
Anderson, Kenneth C. ;
Faham, Malek ;
Facon, Thierry ;
Moreau, Philippe ;
Attal, Michel ;
Munshi, Nikhil C. .
BLOOD, 2015, 126 (23)
[42]   Artificial DNA Templates for the Correction of PCR Bias in Next Generation Sequencing Based MRD Analysis for Childhood Acute Lymphoblastic Leukaemia: The Influence of Secondary DNA Structure [J].
Moppett, John ;
Hancock, Jerry ;
Duez, Marc ;
Bartram, Jack ;
Wright, Gary ;
Hubank, Mike ;
Archer, Paul ;
Williamson, Helen ;
Wakeman, Stephanie .
BLOOD, 2016, 128 (22)
[43]   Ultrasensitive Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML) Using a Targeted Next Generation Sequencing (NGS) Panel [J].
Duchstein, Lara ;
Sloane, Hillary S. ;
Fredebohm, Johannes ;
Ryder, Matthew .
BLOOD, 2020, 136
[44]   Prognostic value of minimal residual disease (MRD) in childhood acute lymphoblastic leukemia (ALL) using polymerase chain reaction (PCR) [J].
Katsibardi, K. ;
Palathanasiou, C. ;
Moschovi, M. ;
Karamolegou, K. ;
Lambrou, G. I. ;
Tzortzatou-Stathopoulou, F. .
PEDIATRIC BLOOD & CANCER, 2007, 49 (03) :387-387
[45]   Minimal Residual Disease Detection in Adults with Acute Lymphoblastic Leukemia By Next Generation Sequencing: Impact on Clinical Outcomes [J].
Cervantes, Lissette ;
Wang, Lan ;
Yaghmour, George ;
Varnavski, Andrei ;
Siddiqi, Imran .
BLOOD, 2020, 136
[46]   In vitro resistance to prednisolone is related to minimal residual disease (MRD) after induction therapy in childhood acute lymphoblastic leukemia (ALL) [J].
de Haas, V ;
Kaspers, GJL ;
Oosten, L ;
Bresters, D ;
Wijkhuijs, AJM ;
van den Berg, H ;
van der Schoot, CE .
LEUKEMIA, 2001, 15 (03) :510-510
[47]   In vitro resistance to predulsolone is related to minimal residual disease (MRD) after induction therapy in childhood acute lymphoblastic leukemia (ALL) [J].
de Haas, V ;
Kaspers, GJL ;
Oosten, L ;
Bresters, D ;
Wijkhuijs, AJM ;
van Wering, ER ;
van den Berg, H ;
van der Schoot, CE .
LEUKEMIA, 2001, 15 (12) :2014-2015
[48]   Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients [J].
Rodrigo Fonseca ;
Mariano Arribas ;
Julia E. Wiedmeier-Nutor ;
Yael N. Kusne ;
Miguel González Vélez ;
Heidi E. Kosiorek ;
Richard (Duke) J. Butterfield ;
Ilan R. Kirsch ;
Joseph R. Mikhael ;
A. Keith Stewart ;
Craig Reeder ;
Jeremy Larsen ;
P. Leif Bergsagel ;
Rafael Fonseca .
Blood Cancer Journal, 13
[49]   New Alternatives for the Evaluation of Minimal Residual Disease (MRD) Detection By Next Generation Sequencing in Multiple Myeloma [J].
Medina, Alejandro ;
Jimenez, Cristina ;
Puig, Noemi ;
Sanchez-Vega, Beatriz ;
Flores-Montero, Juan ;
Gonzalez, Marcos ;
Calasanz, Maria Jose ;
Ayala, Rosa M. ;
Sarasquete, Maria E. ;
Paiva, Bruno ;
Cedena, Maria Teresa ;
Fernandez-Mercado, Marta ;
Rapado, Inmaculada ;
Rosinol, Laura ;
Ocio, Enrique M. ;
Oriol, Albert ;
Alcoceba, Miguel ;
Hernandez, Miguel T. ;
Martinez, Rafael Martinez ;
Mateos, Maria-Victoria ;
Lahuerta, Juan-Jose ;
Blade, Joan ;
Orfao, Alberto ;
San Miguel, Jesus F. ;
Martinez-Lopez, Joaquin ;
Garcia-Sanz, Ramon .
BLOOD, 2017, 130
[50]   Minimal residual disease (MRD) analysis in Non-MRD based ALL ICBFM 2002 protocol for childhood ALL: Is it possible to omit minimal residual disease in risk stratification? [J].
Fronkova, Eva ;
Avigad, Smadar ;
Chik, Ki Wai ;
Castillo, Luis ;
Sigal, Manor ;
Reznickova, Leona ;
Zdrahalova, Katerina ;
Skocovska, Tatana ;
Schrappe, Martin ;
Conter, Valentino ;
Izraeli, Shai ;
Li, Chi Kong ;
Stark, Batia ;
Hrusak, Ondrej ;
Mejstrikova, Ester ;
Stary, Jan ;
Trka, Jan .
BLOOD, 2006, 108 (11) :643A-643A